Esposizione professionale a chemioterapici antiblastici - Bibliomed
Esposizione professionale a chemioterapici antiblastici - Bibliomed
Esposizione professionale a chemioterapici antiblastici - Bibliomed
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2. Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A, McLennan MT. Landmark<br />
article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis( ß -chloroethyl)amine<br />
hydrochloride and tris( ß -chloroethyl)amine hydrochloride for Hodgkin’s disease, lymphosarcoma,<br />
leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M.<br />
Wintrobe, William Dameshek, Morton J. Goodman, Alfre d Gilman and Margaret T. McLennan.<br />
JAMA 1984;251(17):2255-61.<br />
3. Chabner BA, Ryan DP, Paz-Ares L, Garcia -Carbonero R, Calabresi P. Antineoplastic agents. In:<br />
Hardman JG, Limbird LE (Ed.). Goodman & Gilman’s. The pharmacological basis of therapeutics.<br />
New York: McGraw Hill; 2001. p. 1389-459.<br />
4. Howell S, Shalet S.Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin<br />
North Am 1998;27(4):927-43.<br />
5. Schrader M, Heicappell R, Muller M, Straub B, Miller K. Impact of chemotherapy on male fertility.<br />
Onkologie 2001;24(4):326-30.<br />
6. Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet Gynecol Clin North Am<br />
1998;25(2):323-9.<br />
7. Luecke RH, Wosilait WD, Young JF. Mathematical representation of organ growth in the human<br />
embryo/fetus. Int J Biomed Comput 1995;39(3):337-47.<br />
8. Partridge AH, Garber JE. Long-term outcomes of children exposed to antineoplastic agents in utero.<br />
Semin Oncol 2000;27(6):712-26.<br />
9. Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man, chromosomal aberrations<br />
antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res<br />
1975;22:57-155.<br />
10. Rieche K. Carcinogenicity of antineoplastic agents in man. Cancer Treat Rev 1984;11(1):39 -67.<br />
11. Falck K, Grohn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses<br />
handling cytostatic drugs. Lancet 1979;1(8128):1250 -1.<br />
12. Cloak MM, Connor TH, Stevens KR, Theiss JC, Alt JM, Matney TS, Anderson RW. Occupational<br />
exposure of nursing personnel to antineoplastic agents. Oncol Nurs Forum 1985;12(5):33-9.<br />
13. Fishbein L. Perspectives on occupational exposure to antineoplastic drugs. Arch Geschwulstforsch<br />
1987;57(3):219-48.<br />
14. Sessink PJ, Bos RP.Drugs hazardous to healthcare workers. Evaluation of methods for monitoring<br />
occupational exposure to cytostatic drugs. Drug Saf 1999;20(4):347-59.<br />
15. Carmignani SS, Raymond GG. Safe handling of cytotoxic drugs in the physician’s office: a<br />
procedure manual model. Oncol Nurs Forum 1997;24(1 Suppl):41-8.<br />
16. Watson AD, Peaston AE, Malik R, Swinney GR. Guidelines for handling antineoplastic and<br />
immunosuppressive drugs. Aust Vet J 1997;75(12):868 -76.<br />
17. Gruppo di lavoro dell’Associazione Italiana di Medicina Preventiva dei Lavoratori della Sanità.<br />
Summary of recommendations for a rational implementation of the ministry of health guidelines on<br />
the prevention of occupational risks in handling antineoplastic agents. Med Lav 2001;92(2):137-48.<br />
18. Ben-Ami S, Shaham J, Rabin S, Melzer A, Ribak J. The influence of nurses’ knowledge, attitudes,<br />
and health beliefs on their safe behavior with cytotoxic drugs in Israel. Cancer Nurs<br />
2001;24(3):192-200.<br />
19. Deschamps FJ, Marinutti-Liberge V. Risks associated with exposure to cytostatics in health care<br />
personnel. Presse Med 2001;30:1596-600.<br />
20. Schena D, Barba A, Costa G. Occupational contact urticaria due to cisplatin.<br />
Contact Dermatitis 1996;34(3):220-1.<br />
31
Change language